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ABSTRACT
Background and Objectives: In addition to diagnostic criteria, a broad range of nonspecific clinical features can be found in 
patients with Kawasaki disease. This lack of specificity may cause confusion with other febrile illnesses and delay the diagnosis 
of Kawasaki disease. The purpose of this study is to describe common associated symptoms and their clinical significances in 
children affected with Kawasaki disease. Subjects and Methods: As a retrospective study, we reviewed the medical records 
of 121 children who were treated for Kawasaki disease at Presbyterian medical center from January 2005 to June 2010. All clini-
cal symptoms, laboratory data and echocardiographic findings in patients with KD were collected and analyzed. Results: We 
found that there are 9 associated symptoms, namely cough, rhinorrhea, sputum, abdominal pain, vomiting, diarrhea, arthral-
gia, headache and seizure, which occur in patients with Kawasaki disease. Among the study group, there were only 32 children 
with no associated symptoms (26.4%). Patients with abdominal pain and headache had an older mean age than those with-
out such symptoms. The incidence of seizure was significantly higher in incomplete Kawasaki disease patients compared 
with those with complete Kawasaki disease. Vomiting was highly associated with IVIG non-responder group. Conclusion: 
To decrease the incidence of serious coronary complications due to delayed diagnosis, physicians need to be aware of the 
manifestations of Kawasaki disease and the possibility of associated symptoms, which, being unspecific, may otherwise not 
raise any red flags. (Korean Circ J 2011;41:394-398)
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Introduction
Kawasaki disease (KD) is an acute, febrile, multi-systemic 
vasculitis of unknown etiology, first reported by Kawasaki et 
al.
1) KD is known as self-limiting, even in the absence of spe-
cific therapy.
2) However, coronary artery aneurysm (CAA) or 
ectasia develop in 15-25% of untreated patients with the dis-
ease. These sequelae may lead to myocardial infarction, isch-
emic heart disease or sudden death.
3-5) Early detection and 
prompt initiation of therapy with high dose intravenous im-
munoglobulin (IVIG) plus aspirin can reduce the incidence of 
serious coronary artery complications.
6-8) Therefore, accurate 
and timely diagnosis of KD is critical. Because of the absence 
of a specific diagnostic tests or pathognomonic clinical features, 
physicians must rely upon the presence of specific clinical cri-
teria and laboratory data that support the diagnosis of KD, 
while excluding other illnesses that could mimic the disease. 
However, in many cases, these clinical criteria for KD may not 
all present on any given day and not all patients with KD have 
all specific clinical features. Moreover, some patients often have 
other associated symptoms which may delay KD diagnosis and 
thus increase the incidence of coronary artery complications.
Few data have been reported on common associated symp-
toms. The aim of this study was to describe clinical feature, es-
pecially common associated symptoms and its clinical signifi-
cances in children affected with KD.
Subjects and Methods
We reviewed the medical records at Presbyterian medical cen-
ter, retrospectively, of all patients with KD from January 2005 to 
June 2010. Clinical profiles, initial laboratory data, echocardio-
graphic findings and follow-up data were collected from each Sang Hyun Yun, et al.   395
medical record. All clinical symptoms were initially obtained 
both from observation and interview of primary caregivers.
The diagnoses of KD was confirmed by a pediatrician, based 
on the American Heart Association and the Japanese Ministry 
of Health and Welfare criteria.
9-11) This diagnosis included 
the presence of 5 days of fever and ≥4 of the following 5 prin-
cipal clinical features:
1) Bilateral bulbar conjunctival injection without exudate
2) Changes in lips and oral cavity
3) Polymorphous exanthema
4) Changes in extremities
5) Cervical lymphadenopathy
Patients with fever for 5 days and <4 principal features can be 
diagnosed as having KD when coronary artery lesion (CAL) is 
detected by 2-dimensional (2D) echocardiography. Diagnosis 
of incomplete KD (IKD) was made when clinical manifesta-
tions did not fulfill the diagnostic criteria and other diagnoses 
were excluded. Symptoms frequently associated with KD and 
elevated inflammatory indices during the acute phase were 
considered as supportive findings for the diagnosis of IKD.
9)11) 
IVIG-responder was defined as patients who received a single 
dose of IVIG treatment and their fever subsided within 48 
hours and inflammatory indices showed marked improve-
ment. IVIG-non-responder was defined as patients who need-
ed a second dose of IVIG because of a reappearance of fever 
within 48 hours after initial IVIG treatment. All patients were 
treated with both an IVIG (2 g/kg) and aspirin (80-100 mg/kg/
day) during the acute phase of KD.
All patients underwent 2D echocardiography of the coronary 
arteries. Normal internal diameters of the coronary arteries 
were defined as 2.5 mm or less, in patient with body surface area 
(BSA) of less than 0.5 m
2, 3 mm or less in those with BSA be-
tween 0.5 and 1.0 m
2, and 4 mm or less in those of BSA of more 
than 1.0 m
2. Coronary artery dilatation was determined to ex-
ist when coronary artery size was larger than normal, but with 
no apparent segmental aneurysm. CAA was defined when the 
internal diameter of a measured segment was >1.5 times that 
of an adjacent segment.
12)
Data were analyzed using the frequency analysis, descriptive 
statistics, chi-square test, Fisher’s Exact test, independent t-test, 
and binary logistic regression. A p<0.05 was considered statical-
ly significant. All analyses were conducted with Statistical 
Package for the Social Sciences version 18.0.
Results
A total of 121 children with KD were included in the study. 
The mean age at diagnosis was 31.9 months (range: 3-142 
months). The average body weight was 13.61 kg (range: 5.9-
35.5 kg). There were 77 boys (63.6%) and 44 girls (36.4%). 
Among the 121 patients, 38 (31.4%) were IKD. IVIG-non-re-
sponder group contained 10 patients (8.3%), while IVIG-re-
sponder group contained 111 patients (91.7%). Of the 121 pa-
tients, 59 had CAL (48.8%), including 7 CAA (5.8%). Incidence 
of CAL in IVIG-non-responder was significantly higher than 
in IVIG-responder (80% vs. 45.9%, p=0.039).
All patients had a fever at the time of diagnosis. Among the 
five cardinal symptoms, conjunctival injection (84.3%) occurred 
most frequently, followed by polymorphous rash (81.0%) and 
oral mucosal changes (81.0%). Changes of extremities (58.7%) 
and cervical lymphadenopathy (51.2%) occurred less frequent-
ly than did other cardinal symptoms. In addition to major symp-
toms, there were 9 nonspecific associated symptoms that oc-
curred in study subjects: cough was reported in 56 patients 
(46.3%), rhinorrhea in 37 patients (30.6%), sputum in 18 pa-
tients (14.9%), abdominal pain in 15 patients (12.4%), vomit-
ing in 22 patients (18.2%), diarrhea in 19 patients (15.7%), ar-
thralgia in 15 patients (12.4%), headache in 3 patients (2.5%), 
and seizure in 6 patients (5.0%). There were 7 symptoms that 
occurred in more than 10% of study subjects. One or more re-
spiratory symptoms (cough, rhinorrhea, sputum) were pres-
ent in 66 patients (54.5%). Forty-one (41) patients (33.9%) had 
at least gastrointestinal symptoms (vomiting, diarrhea or ab-
dominal pain). There were 32 (26.4%) children with no asso-
ciated symptoms.
We analyzed the relationship of the common associated symp-
toms to patient age. Patients with abdominal pain and head-
ache symptoms had an older mean age than those without such 
symptoms (p=0.001 and p=0.043, respectively) (Table 2). The 
incidence of associated symptoms did not significantly differ 
according to gender or days of illness at diagnosis.
Compared with IKD, the incidence of major symptoms that 
were using classic diagnostic criteria were higher in complete 
KD. Among the associated symptoms, the incidence of seizure 
Table 1. General characteristics in all study subjects
Total Complete KD Incomplete KD p
Total N (%) 121 83 (68.6) 38 (31.4)
Gender Male, n (%) 77 (63.6) 56 (67.5) 21 (55.3) 0.195
Body weight (kg) Mean±SD 13.6±4.80 13.5±4.20 13.8±5.90 0.753
Age (months) Mean±SD 31.8±23.8 31.4±21.1 32.8±29.2 0.762
IVIG non-responder (%) 10 (8.3)0 10 (12)0. 0 (0)0.  0.030*
CAL+ (%)* 59 (48.8) 47 (56.6) 12 (31.6)  0.011*
*p<0.05. KD: Kawasaki disease, IVIG: intravenous immunoglobulin, CAL+: Patients with coronary artery lesions396   Associated Symptoms of KD
was significantly higher in IKD patients (Table 3). The inci-
dence of CAL and IVIG-non-responder was significantly high-
er in complete KD than IKD (Table 1). In laboratory data, acute 
inflammatory indices (white blood cell count, erythrocyte sed-
imentation rate, C-reactive protein), aspartate aminotransfer-
ase and alanine aminotransferase were more elevated in com-
plete KD patients, but not significant between both groups. 
However, the incidence of sterile pyuria was significantly high-
er in complete KD patients {complete KD vs. IKD: 39 patients 
(47%) vs. 10 patients (26.3%), p=0.032}. There were no signifi-
cant differences between complete and IKD patients in terms 
of gender, mean age, and average body weight.
We also explored whether clinical symptoms were associ-
ated with development of CAL and IVIG responsiveness. The 
results indicated that there were no statistical differences in 
the incidence of clinical symptoms (major and minor symp-
toms) between the KD patient groups with or without CAL. 
There were, however, 45 (76.3%) patients who had one or more 
associated symptoms among the KD patients with CAL (Table 
4). Interestingly, only the symptom of vomiting was significant-
ly associated with the IVIG non-responder group (Table 5).
Discussion
After the first case of KD was reported by Dr. Kawasaki in 
1967, it has become the leading cause of acquired heart dis-
ease during childhood in many countries. Despite extensive 
investigation, the etiology of KD remains unknown, so the di-
agnosis depends on non-specific clinical signs rather than a de-
finitive laboratory test. In addition to the diagnostic criteria, a 
broad range of non-specific clinical features are associated with 
KD, including irritability, uveitis, aseptic meningitis, seizure, 
severe lethargy, semicoma, cough, rhinorrhea, abdominal 
pain, vomiting, diarrhea, hepatic dysfunction, gallbladder 
hydrops, parotitis, urethritis, arthralgia.
2)9)13-15)
We found that associated symptoms such as cough, rhinor-
rhea, sputum, abdominal pain, vomiting, diarrhea, arthralgia, 
headache and seizure commonly occur in patients with KD. 
Although, we can’t completely rule out the possibility that as-
sociated symptoms result from concurrent infections we sus-
pect that these symptoms may reflect diffuse vasculitis or be 
the sequelae of an infectious trigger of KD.
Few previous reports quantify the prevalence of associated 
symptoms in KD. In an early retrospective review, Hicks and 
Melish
14)15) described their experience with KD, reporting that 
sterile pyuria reflecting urethritis is found in about 75% of pa-
tients. Additionally, arthritis occurred in 30% of KD patients 
and about one third of patients with arthritis have onset in the 
first 10 days of illness. In about 30% of the patients, gastroin-
testinal complaints, including abdominal pain, diarrhea and 
nausea, presented. CNS involvement with severe lethargy, semi-
coma, and aseptic meningitis occurs in 25% of patients. Also, 
obstructive jaundice and acute hydrops of the gallbladder are 
seen in about 5% of the patients. Park et al.
16) reported that many 
Table 2. Age of patients (mean±SD) according to symptoms
Symptoms Present Not present p
Cough 31.9±21.4 31.9±26.0 0.998
Rhinorrhea 29.6±26.4 32.9±22.7 0.489
Sputum 28.8±17.9 32.4±24.8 0.554
Abdominal pain 50.9±15.6 29.2±23.6  0.001*
Vomiting 40.4±24.5 30.0±23.4 0.064
Diarrhea 24.4±21.9 33.3±24.0 0.139
Arthralgia 38.3±23.5 31.0±23.9 0.269
Headache 59.3±29.2 31.2±23.4  0.043*
Seizure 21.2±14.8 32.4±24.1 0.261
*p<0.05
Table 3. Comparison of associated symptoms between complete and incomplete KD
Complete KD Incomplete KD p
N (%) 83 (68.6) 38 (31.4)
Cough (%) 39 (47)0. 17 (44.7) 0.818
Rhinorrhea (%) 25 (30.1) 12 (31.6) 0.872
Sputum (%) 09 (10.8) 09 (23.7) 0.065
Abdominal pain (%) 8 (9.6) 07 (18.4) 0.174
Vomiting (%) 16 (19.3) 06 (15.8) 0.644
Diarrhea (%) 12 (14.5) 07 (18.4) 0.578
Arthralgia (%) 13 (15.7) 2 (5.3) 0.142
Headache (%) 2 (2.4) 1 (2.6) 1.000
Seizure (%) 1 (1.2) 05 (13.2)   0.012*
One more respiratory symptoms (%) 46 (55.4) 20 (52.6) 0.775
One more GI symptoms (%) 27 (32.5) 14 (36.8) 0.642
No associated symptoms (%) 20 (24.1) 12 (31.6) 0.386
*p<0.05. KD: Kawasaki disease, GI: gastrointestinalSang Hyun Yun, et al.   397
school-aged patients with KD have incomplete presentation 
and occasionally show additional symptoms including abdomi-
nal pain, respiratory symptoms, headache, vomiting and ar-
thralgia. Cho et al.
17) reported that respiratory symptoms were 
observed in 69% of KD patients but the association between 
a respiratory virus and KD was not found. Baker et al.
18) report-
ed that nonspecific symptoms commonly occur in children 
with KD, finding that nine symptoms occurred in more than 
10% of study subjects during the early phase of disease. They 
also noted that patients with irritability and rhinorrhea had a 
younger mean age than did those without these symptoms. In 
addition, the patients with symptoms of vomiting, abdominal 
pain and arthralgia were older than those without such symp-
toms. These results are similar to those that we found; in our 
study, seven common associated symptoms occurred in more 
than 10% of patients with KD. Also, patients with headache 
and abdominal pain were older than those without such symp-
toms. But, subjective symptoms such as abdominal pain, ar-
thralgia and headache seem to become more prevalent with 
higher patient age, because older patients have better ability 
to understand and articulate their symptoms. Thus, further ob-
servations and studies are required to get more precise result.
There have been many studies done to determine factors 
related to the development of CAL and IVIG responsiveness 
over several years, however there has been little research into 
trying to ascertain the relationship between either occurrence 
of CAL and symptoms in KD, and IVIG responsiveness and 
symptoms in KD. This study tried to find out whether there 
were any relations between the existence of the associated symp-
toms in children with KD and the occurrence of CAL, between 
the number of symptoms in KD and the occurrence of CAL, 
between the existence of the associated symptoms in KD and 
Table 4. Comparison of associated symptoms between patients with CAL and without CAL
CAL+* CAL-† p
N (%) 59 (48.8) 62 (51.2)
Cough (%) 28 (47.5) 28 (45.2) 0.800
Rhinorrhea (%) 22 (37.3) 15 (24.2) 0.118
Sputum (%) 07 (11.9) 11 (17.7) 0.364
Abdominal pain (%) 08 (13.6) 07 (11.3) 0.705
Vomiting (%) 13 (22.0) 09 (14.5) 0.284
Diarrhea (%) 11 (18.6) 08 (12.9) 0.386
Arthralgia (%) 06 (10.2) 09 (14.5) 0.468
Headache (%) 1 (1.7) 2 (3.2) 1.000
Seizure (%) 2 (3.4) 4 (6.5) 0.680
One more respiratory symptoms (%) 35 (59.3) 31 (50)0. 0.303
One more GI symptoms (%) 21 (35.6) 20 (32.3) 0.698
No associated symptoms (%) 14 (23.7) 18 (29.0) 0.509
*A group with coronary artery lesions, †A group without coronary artery lesions. GI: gastrointestinal, CAL: coronary artery lesion
Table 5. Comparison of associated symptoms between IVIG responders and non-responders
Responder Non-responder p
N (%) 111 (91.7)0 10 (8.3)00
Cough (%) 53 (47.7) 3 (30.0) 0.337
Rhinorrhea (%) 36 (32.4) 1 (10.0) 0.280
Sputum (%) 17 (15.3) 1 (10.0) 1.000
Abdominal pain (%) 13 (11.7) 2 (20.0) 0.359
Vomiting (%) 15 (13.5) 7 (70.0)   0.004*
Diarrhea (%) 16 (14.4) 3 (30.0) 0.191
Arthralgia (%) 11 (9.9)0 4 (40.0) 0.061
Headache (%) 3 (2.7) 0 (0)00. 1.000
Seizure (%) 6 (5.4) 0 (0)00. 1.000
One more respiratory symptoms (%) 62 (55.9) 4 (40.0) 0.509
One more GI symptoms (%) 33 (29.7) 8 (80.0)   0.003*
No associated symptoms (%) 31 (27.9) 1 (10.0) 0.288
*p<0.05. GI: gastrointestinal, IVIG: intravenous immunoglobulin398   Associated Symptoms of KD
IVIG-responsiveness, and between the number of symptoms 
in KD and IVIG-responsiveness through statistical analysis. 
There were no meaningful statistical correlations except for a 
few more vomiting symptoms in IVIG-non-responders (p= 
0.004). Despite this correlation, we do not have a clear expla-
nation for why this occurs, but we think some inflammatory 
mediators that associated with IVIG-non-responders may af-
fect the development of such symptoms. Because this study 
was implemented in only one institution, more studies are 
needed to statistically validate this study.
Although associated symptoms do not contribute to the 
principal criteria for diagnosis and treatment of KD, these 
symptoms may cause confusion with other common febrile ill-
nesses and delay the diagnosis of KD. It should be emphasized 
that the clinical signs of KD are often not all present at any one 
point in time and that nonspecific associated symptoms might 
occur in KD patients occasionally. The presence of these symp-
toms should not cause the physician to discount the possi-
bility of KD in patients with characteristic clinical findings.
The limitations of this study include its retrospective na-
ture and relatively small sample size. Our study is restricted to 
a single center experience and thus cannot represent general 
characteristics of all KD patients, therefore a large multi-cen-
ter-based investigation needs to take place in order to get a 
more precise result.
In conclusion, to decrease the incidence of serious coronary 
artery complications due to delayed diagnosis of Kawasaki dis-
ease, clinicians should certainly be aware of all of the manifes-
tation of KD and the possibility of associated symptoms. Fur-
thermore, careful evaluation of clinical findings and early study 
of echocardiography are needed.
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